ࡱ> /1.a jbjbdd 0ee @@@@@@@XXXX d ,KR:@: @@O   @@  T$x@@@@   @@  `Xj  e0 7 7  @ddCANCER BRIEFING 1 An Overview NEW CANEW CASES 2003 (excluding Non-Melanoma Skin Cancer- see note later) SCOTLAND UK WORLD Male 12,612 138.014 5,801, 839 Female 13,336 137,226 5.060,657 Total 25,946 275,280 10.826,486 In 2001 Male 11,812 Female 12,710 Total 24,522 circa 10.100.000 In the UK there was an overall cancer incidence increase of 15% in men and 29% in women between 1975 and 2002 DEATHS 2005 Male 7.637 80,044 3,390,545 Female 7450 73,353 3,490, 957 Total 15,087 153,397 6,723,817 A Holocaust every year Between 1995 and 2005, in the UK there was a decrease in deaths of 13% in men and of 5% in women Worldwide there was an increase of 18% between 1990 and 2005 LIFETIME RISK FOR ALL CANCERS The usual figure given is 1:3 for getting the disease and 1:4 for dying from it. However, Cancer Research UK quotes a 40% lifetime risk for all cancers, That is 1:2.5 not 1:3 This fits with the N American lifetime risk. SURVIVAL AT 5 YEARS FOR ALL CANCERS Males 33.9% Females 42.5% There is a wide range of survival times. Lung M 7% F 6.4% Breast 85.9*%. Prostate 49.6% Testis 93% Pancreas 4% Reminder: survival is not synonymous with cure. There are long- term health effects from original disease or treatment on patient. There are both stress and economic burdens on the whole family. See the reference to long term effects on health of adult survivors of childhood cancer in briefing 5 and information on survivors of breast cancer in briefing 2. All stats are from Information and Statistics Department of the NHS, from Cancer Research UK and International Agency for Research on Cancer of the WHO. unless stated otherwise. The way the figures are presented here depends on how they are presented in the original sources. Death rates are more recent than incidence rates because they are more readily recorded 67=[s4 5  0 2 A !ķ hh( heh( B*phhwh( >*hwh( >*B*phhwh( B*phhRh( B*phhLh( B*phh }h( B*phh( hLh( B*ph  !"lm%\5 _ 1 2  A    B C J [ o | !7.:p( |. A!"#$% N@N ~ Normal%B*CJOJQJaJmH ph...sH tH DA@D Default Paragraph FontRi@R  Table Normal4 l4a (k@(No List  + +  !"lm%\5_12ABCJ[o| ! 7 0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ000ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ0ʀ !"lm%\5_12ABCJ[o| ! 7 Cx0Cx0Cx0Cx0Cx0Cx0Cx0Cx0Cx0Cx0Cx0Cx0Cx0Cx0Cx0@btxbmun2o"@btxbmun2o"@btxbmun2o"@08@08@08@08@08@08@08@08@08@08@08@08@08@08@08@08@08@08@08@08@08@08@08@08@08@08@08@08@08@08@08"""0 @3\8@3\8@3\8@3\8@3\80    osy :::::::@ ]  H @ @UnknownGTimes New Roman5Symbol3 Arial hf 8$24d@yECANCER BRIEFING 1 An Overview Morag Parnell Morag Parnell Oh+'0 $ @ L Xdlt|' CANCER BRIEFING 1 An Overview Morag ParnellNormalMorag Parnell3Microsoft Word 11.3@vA@rA@3 8GPICTZ HHZ ZHH(T(TZZ         <{Z{Z {{Z{G~~~~~1~9~~{9~~~~9~~s~      ]Z{{{{{{ {{{{{{{{s{{s9~~~~Z~~~~~~~~~9o{^g9o{^ZVZg9Z^^s^V^c^o{Z^co{^g9Z^g9^kZc^^{{޾^cVVkZ^kZo{   ){9{Z9Z5~~~~~{~s~~~{  >{{sw{s{s{{wss{sF^Vo{^kZcckZckZkZcckZ^ckZckZ^Es{{{so{sswwswswwo{=kZ^^o{ZV9~kZkZo{ccco{Hw{{{{Z{{{{{Mo{cRo{~~~~~~Z~~~~9~~~~~~~  {~s~~~9{{{s{s%^Vo{^kZkZckZc%s{{Z{)kZ^^o{ZV9~Z9~<w{{{{{{{{Bo{cRo{~~~~~ Z9~9~9~~~   Ewo{wwwwwwwskZwwNsNsVcNsNs#Vg9VRNsZRVZ^Vg9RkZcRVcVg9NsckZRVVcVNscg9VRZVZ VkZkZVVkZVVRVR2o{o{kZwwwo{kZswo{M^VVkZNsRsZVkZVVRVg9RRVVg9VkZZRVR^ZZ^  Z{Z{~~99~s~~ֿ  9{o{wso{s{{sw{wD^Vo{^o{ckZo{c^^kZkZ^cc^cEs{o{{wso{sswss{ssswo{IkZ^^o{ZVo{^cco{kZkZckZkZ^^c^co{Kw{{wsso{{wssso{Z{{{ZMo{cRo{kZccco{kZckZkZ^o{~Z~9~9Z3~~Z~~~~9~~R9~~~~9  co{{ssw{s w{{s{{{{{{{so{{R^kZZZ^^kZ^^cZ^Zc)o{^kZ^^g9ZV^kZNswZcZZ^g9kZ^ZRVZ^ZVcco{kZkZ^o{V{{wo{{5^V^Z^Zco{c^o{o{^Zwc^V^O w{{{{{{{so{{{s{swn$cg9c^ZZR^V^kZ^ZwZcZ^Vg9kZ^ZRc^c^o{Z^Rw^kZ^^cZ^Zc   C{{{Z{{{9{Z{Z{E~~~Z{~{~~s~9~~~~~~~~~cswwwwwo{wwwww wwwwwwwwkZV7ZF1kZkZJRVg9VRkZ^VVkZZg9g9Rg9RVg9NsRNsVRRVRZVRVRg9VRg9R^kZVRZZVkZZK{Z{{Z99~~~~~9~s~~9~~~~9~~s~~~~s~~~~~ZZ~s9~sZ~9~~~9~Z~~~9~'{{( Z~~9Z~9~~~~9BswwwwwwwwwwwwMkZVRkZNsRsF1g9VVckZZRkZVZcRVkZNsg9NskZVg9RZ  UskZww{{{wwws{o{ssskZ{s{{o{so{sS^g9^ccckZckZccg9ZkZg9^wcg9^g9^^g9w^  {so{%^Vo{^ckZkZ^^o{!s{{swo{) kZ^^o{ZVc^cc^o{   1w{{{{{{{Ko{^^kZ^o{cZZwV^R^Z^co{c^kZZcRkZVo{^c  {޶c^^Zֹ{{o{o{^so{^o{sw{o{kZc^^o{o{swswo{) RkZ^ZckZcc^{^o{o{{swo{' g9kZccRV^^c^o{              ՜.+,0 `hpx  ' CANCER BRIEFING 1 An Overview Title  !"#$%'()*+,-0Root Entry F+ 21Table7WordDocument0SummaryInformation(DocumentSummaryInformation8&CompObjX FMicrosoft Word DocumentNB6WWord.Document.8